The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is now accepting applications for our 2022 KL2 Scholars Program. The pre-application is due April 8, 2022 with the final application due May 31, 2022. Funding is expected to begin between July-November 2022, to allow for any continued uncertainties due to the pandemic.

During its first ten years, the GHUCCTS has been privileged to award KL2 support to 21 junior faculty colleagues from Georgetown and Howard Universities and from MedStar Health, who have leveraged this opportunity in order to publish >500 peer-reviewed manuscripts, receive over 50 extramural grants and conduct 30 sponsored clinical trials.

This  K-series  career  development award  is  nearly identical to our previous KL2 awards and analogous to individual  K23,  K08, or K01 awards, with a focus on developing early-career (MD or equivalent; doctorally-trained  nurses, pharmacists or dentists; and clinically or translationally-oriented  PhD)  faculty  investigators  through  an inter- or multi-disciplinary mentored translational research experience so that they can become independent, extramurally-funded investigators. Given the goals of the GHUCCTS, awards will favor those: 1) who propose novel trans-, inter-, or multi-disciplinary and collaborative/team research projects;, 2) from the entire T1-T4 translational continuum; 3) which span departments, disciplines, and institutions; and, 4) address significant health disparities.

For more details, including application instructions, visit our KL2 Scholars page or download the RFA announcement.